Banker pitch at HQ last week; raise of $3.3-5.6 billion may value HMIL up to $28 billion. At $28 billion, HMIL will be valued at 48 times FY23 earnings, while at the lower end of the band at $22 billion, it would be 38.4 times. Maruti Suzuki trades at 40 times FY23 earnings.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the